CEO Santo J. Leo Featured on Blog

I am excited to announce that I was recently featured on the Trustpilot blog, in an article titled: Trustpilot Everywhere – how our customers succeed by promoting their reputation across all channels.

The article focused on the integration of Trustpilot reviews in marketing campaigns to instill trust in potential customers. It highlighted some of the most successful advertising campaigns across the world, including for incorporating Trustpilot reviews in its national television commercials.

One of the key points I shared in the article was the use of storytelling in validating our customer’s experience:

“By utilizing Trustpilot reviews, we have an opportunity to let our customers tell others their story to not just friends and family, but the country. These stories validate the customer experience… has reinvented the pharmacy experience, and we are using Trustpilot to reinvent storytelling.”

Aside from outlining the most effective campaigns the article also reiterates the impact of online reviews on customers purchasing decisions.

Trustpilot reviews have become an essential part of our business as they help us strengthen the conversation with current, new and potential customers.

Customer feedback is becoming a necessity for any business looking to grow and increase customer confidence at different touch points of the buying journey. We believe that brands must always put people at the heart of their marketing strategy to create authentic campaigns and Trustpilot has been an excellent tool for this.

At we are committed to providing our customers excellent service and thoughtful care and what better way to do this than by building healthy relationships with them.

To read the full article, visit: featured on NBC’s WPTV 5

Original Link:

BOCA RATON, Fla. – A Boca Raton start-up is turning the conventional pharmacy upside down. The founder of said it can save you thousands of dollars on medication.

Joel Neiberg is a busy man. The general contractor takes about ten pills a day to keep him going. Even with health insurance, he was paying hundreds of dollars out of his own pocket every month for those prescriptions.

“It was almost $500 or $600 a month,” he said. “My prices came down to about $60 or $70 per month.”

Enter Santo Leo launched the company in Boca Raton last year. It’s basically a wholesale pharmacy that mails your medication to your home.

“A pretty simple structure for a complicated process overall,” Leo said.

A $5 monthly membership allows you to buy medication prescribed by your doctor for the same price the pharmacy pays.

Leo said the drugs come from the same distributors that supply CVS or Publix, but without the markup.

“On average our savings are 93 percent,” Leo boasted.

We compared costs for generic Crestor, Prilosec and Zocor. Across the board, was cheapest.

“It’s transparent, it’s wholesale, there are no discounts, what you see is what you get,” Leo said.

The pharmacy doesn’t accept insurance. Licensed pharmacists call your doctor to verify each prescription.

Neiberg thought it sounded too good to be true. Now, he swears by it which is good news because he’ll have prescriptions to fill for years to come.

“I’ll be on these, per my doctor, pretty much for the rest of my life,” the contractor admitted.

For more information on the concept, visit the pharmacy’s website by clicking here.

Santo Leo featured in LifeZette article

The Worst Possible Choice: Food or Medicine

The skyrocketing premiums a majority of Americans face for their health insurance in 2017, along with a diminishing choice of care, are dominating headlines — and rightly so. Yet access to the prescription drugs we need and the prices we pay for them are perhaps of most concern.

“Almost every pharmacist in the country has seen customers who have to choose between medication and food,” said Santo J. Leo, CEO of in Boca Raton, Florida. “Pharmacies aren’t allowed, legally, to help these people pay for their medications because it’s considered a kickback. We need some real reforms to the system ASAP.”

The latest Kaiser Family Foundation poll shows Americans believe the high cost of prescription drugs needs to be a top health-care priority for the next president and Congress. The survey found that “making sure high-cost drugs for chronic conditions, such as HIV, hepatitis, mental illness and cancer are affordable to those who need them” is viewed as a “top priority” by 74 percent of the public — across party lines.

Pharmaceutical company Mylan NV continues to come under intense scrutiny for increasing the price of its EpiPen by more than 500 percent, to a price of $494 to $795 for a two-pack (according to prices from GoodRX). While most Americans are familiar with that case, Mylan is not alone in aggressively jacking up prices of life-saving drugs.

Gilead Sciences rolled out a drug called Epclusa this past June to treat all viral forms of hepatitis — at a price of $74,760 for a 12-week treatment. The company had previously produced drugs that target other strains of hepatitis: Sovaldi, priced at $84,000, and Harvoni, which cost $94,500.

ARIAD raised the price of its drug Iclusig to treat chronic myeloid leukemia by 8 percent each quarter, until it reached a 39-percent increase, taking the price tag from $120,000 to $200,000 a year. Lawmakers this month formally asked for an explanation.

In September 2015, Turing Pharmaceuticals increased the price of the HIV/cancer drug, Daraprim, by over 5000 percent after acquiring rights to the drug a month earlier.

Drug companies are quick to point out the amount of time and money spent on research — but profits don’t lie. The global pharmaceutical industry earns $330 billion per year; that number is expected to rise to $440 billion in three years, according to the World Health Organization. Between 1998 and 2014, the pharmaceutical industry spent $3 billion alone on lobbying efforts.

Drug Lobby Bracing for Battle
  • The pharmaceutical lobby hiked dues for member companies by 50 percent this summer to generate an additional $100 million per year as the industry gears up for a post-election battle over drug prices. The funds will increase the trade group’s coffers to more than $300 million per year.

Gilead Sciences earned a $27.6 billion profit, while Mylan posted a $9 billion profit in 2015. Iclusig generated sales of $65.3 million in the second quarter.

Even when a drug doesn’t prove effective, its manufacturers often use it for another disease or condition — Viagra is just one example. Designed to be used as a high blood pressure and heart disease drug, it failed to be effective for that. Instead, it was repackaged as an erectile dysfunction medication to capitalize on one of its side effects — increased erections in males. Viagra is still highly profitable after 15 years on the market, earning over $1 billion per year for Pfizer.

Two primary factors responsible for the high cost of prescription drugs are market exclusivity and insurance environment, said Dr. Spencer Malkin, CEO of Prescriber’s Choice in Miami, Florida. Market exclusivity occurs when generic and branded manufacturers consolidate or merge, creating a virtual monopoly for drug makers. Using generic forms of a drug once gave the consumer a financial break — but monopolies often prevent savings.

The insurance environment is more complicated. Insurance networks delegate prescription coverage to Pharmacy Benefit Managers (PBMs). PBMs are unregulated and often base prices upon great need or uniqueness of the drug. They also receive rebates from manufacturers and base prices to boost profit potential.

“This creates an unstable environment that deters drug price reductions and encourages higher priced drugs,” Malkin told LifeZette.

It’s where consumers are often taken advantage of, said Leo. “A complete lack of transparency in pricing structure basically creates monopolies. PBMs, which are mostly owned by pharmacies or insurance companies, negotiate pricing in secret and retail pharmacies are contractually obligated to accept that pricing if they accept insurance. This leads to huge markups.”

Leo’s company,, allows consumers to see the wholesale cost of thousands of medications and determine the markup on the drugs they use.  “We need to find a way to cut the wasteful markups and price gouging on everyday maintenance medications. These are often marked up hundreds of percentage points only to line the pockets of PBMs and retail pharmacies.”

With prescription drug use growing in the U.S., a hefty market can be manipulated for gain. A 2013 study by the Mayo Clinic showed 70 percent of Americans take at least one prescription drug, more than half take more than one drug a day — and 20 percent take five or more drugs per day.

Pat Barone, MCC, is a professional credentialed coach and author of the Own Every Bite! bodycentric re-education program for mindful and intuitive eating, who helps clients heal food addictions.

Last Modified: October 31, 2016, 8:57 am